Table 1.

Table showing axial length and refraction of atropine 0.01% treated eyes and placebo treated eyes at 2 years

2 years	Treatment group		Control group		t	P
	Mean	SD	Mean	SD
Axial length
OD	24.65	0.62	24.85	0.74	1.772	0.0785
OS	24.56	0.71	24.86	0.84	2.3283	0.0213
Refraction
OD	−4.21	1	−4.93	1.21	3.8718	0.0002
OS	−4.31	0.93	−5.03	1.2	4.0325	0.0001

Mean axial length of group 1 is 24.62 mm and that of group 2 is 24.85 mm. Mean refraction of group 1 is−4.26 D and that of group 2 is−4.98 D. Mean increase in axial length of group 1 is by 0.11 D and that of group 2 is by 0.32 D as compared to baseline, and mean increase in refraction of group 1 is by 0.39 D and that of group 2 is by 0.88 D as compared to baseline which is highly significant